Focus on Psychosis
Recently published articles about Focus on Psychosis
Original Research
Phase 2b Study to Evaluate Basmisanil as Adjunctive Treatment in Patients With Cognitive Impairment Associated With Schizophrenia
April 15, 2026
Although basmisanil did not improve cognitive deficits, the results offer insight into factors that should facilitate design of more informative trials.
Original Research
Correlates and Predictors of Criminal Legal Involvement in First-Episode Psychosis
March 30, 2026
More than 10% of people with first-episode psychosis are involved in the legal system before (11%) and while (14%) receiving mental health treatment, which can interrupt access to specialty...
Original Research
Effect of Adjuvant Metformin on Adherence to and Persistence of Treatment With SGAs in Nondiabetic Patients
November 17, 2025
Use of metformin with second-generation antipsychotics (SGAs) was associated with improved adherence and persistence to SGAs at both 180- and 365-day follow-up in adults with Medicaid and commercial insurance.
Recent JCP Articles on Focus on Psychosis
Recent PCC Articles on Focus on Psychosis
Original Research
Vision Outcomes in Children With Mental, Emotional, Developmental, or Behavioral Problems
September 10, 2026
This study evaluated whether vision care utilization, screening/referral steps, and vision-related outcomes differ by mental, emotional, developmental, or behavioral disorder status in US children.
Featured Focus on Psychosis Research
Original Research
Severity of Antipsychotic-Induced Cervical Dystonia by Algorithm-Based Rating System
April 15, 2024
Rater consensus data were compared with deviation angle data using AI-based deviation angle measurement technology. With the range of tilt angles found in the study, the authors propose a...
Original Research
The Characteristics and Burden of Cognitive Impairments in Schizophrenia in the US
August 11, 2025
Medical Expenditure Panel Survey data showed that over half of adults with schizophrenia report cognitive impairments, which were associated with higher healthcare costs and lower quality of life.
